History
  • No items yet
midpage
191 A.D.3d 81
N.Y. App. Div.
2020
Read the full case

Background

  • MLMIC, formerly a mutual insurer, converted to a stock insurer; Insurance Law § 7307 and MLMIC's conversion plan provided cash consideration to "eligible policyholders" based on premiums paid during a 3‑year period.
  • Each physician (including Scott) was the named policyholder on his own MLMIC malpractice policy; Maple Medical (the employer) paid the premiums for those physicians as part of employment agreements.
  • Some physicians signed forms naming Maple Medical as "Policy Administrator" (agent for premium payment and certain communications), but none affirmatively designated Maple Medical to receive demutualization cash.
  • DFS approved the conversion plan and expressly treated the policyholder as the presumptive payee while providing an objection/escrow process for disputes about payees.
  • Maple Medical sued to recover cash distributions held in escrow for several physicians; the trial court followed First Department precedent (Schaffer) and awarded the funds to Maple Medical; this appeal followed.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Who is entitled to MLMIC demutualization cash? Maple Medical: payer of premiums should receive proceeds. Scott: statutory plan and policy identify the named policyholder as payee absent written designation. Policyholders (physicians) are entitled to the proceeds unless they affirmatively designated another designee.
How should Insurance Law § 7307 be read re: payee vs. calculation? Maple Medical: premium‑payer language gives payers ownership. Scott: premium language governs allocation amount only, not identity of payee. § 7307 and the conversion plan allocate payment to policyholders; premium language governs formula, not payee.
Unjust enrichment — can Maple Medical recover because it paid premiums? Maple Medical: awarding proceeds to physicians would unjustly enrich them since Maple paid premiums. Scott: premium payments were bargained-for compensation; no mistake, no unjust enrichment. No unjust enrichment: premium payments were part of employment bargain and no mistake or unjust retention exists.
Escrow/release procedure — were funds properly released? Maple Medical: trial court ordered escrow released to it. Scott: conversion plan/stipulation required funds to remain in escrow pending nonappealable order. Trial court erred releasing escrowed funds while appeal pending; funds must remain in escrow until appeals/leave resolved.

Key Cases Cited

  • Schoch v. Lake Champlain OB‑GYN, P.C., 184 A.D.3d 338 (3d Dep't) (policyholder entitled to demutualization proceeds; premium payment affects allocation, not payee)
  • Maple‑Gate Anesthesiologists, P.C. v. Nasrin, 182 A.D.3d 984 (4th Dep't) (same: employer payment of premiums does not entitle employer to proceeds absent designation)
  • Matter of Schaffer, Schonholz & Drossman, LLP v. Title, 171 A.D.3d 465 (1st Dep't) (employer awarded proceeds under unjust enrichment theory)
  • Mandarin Trading Ltd. v. Wildenstein, 16 N.Y.3d 173 (N.Y. 2011) (standard for unjust enrichment)
  • Pappas v. Tzolis, 20 N.Y.3d 228 (N.Y. 2012) (contractual remedies preclude unjust enrichment recovery)
Read the full case

Case Details

Case Name: Maple Med., LLP v. Scott
Court Name: Appellate Division of the Supreme Court of the State of New York
Date Published: Dec 9, 2020
Citations: 191 A.D.3d 81; 138 N.Y.S.3d 61; 2020 NY Slip Op 07366; 2019-09157
Docket Number: 2019-09157
Court Abbreviation: N.Y. App. Div.
Log In